Insulin-Like Growth Factor-I E-Peptide Activity Is Dependent on the IGF-I Receptor

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Brisson, Becky K ^a   Barton, Elisabeth R ^a  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; BIOAVAILABILITY; BIOLOGICAL ACTIVITY; BIOLOGICAL FUNCTIONS; C2C12 CELL LINE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; ENZYME INHIBITION; MOUSE; MYOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PHARMACOLOGICAL BLOCKING; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL MEMBRANE; CELL MOVEMENT; CELL PROLIFERATION; GENE ORDER; INSULIN-LIKE GROWTH FACTOR I; MAP KINASE SIGNALING SYSTEM; MICE; MOLECULAR SEQUENCE DATA; MYOBLASTS; PEPTIDES; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTOR, IGF TYPE 1;

MURINAE; RODENTIA;

EID: 84866650675     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045588     Document Type: Article

References (76)

1. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A, (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75: 59-72.
2. Baker J, Liu JP, Robertson EJ, Efstratiadis A, (1993) Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75: 73-82.
3. Mathews LS, Hammer RE, Behringer RR, D'Ercole AJ, Bell GI, et al. (1988) Growth enhancement of transgenic mice expressing human insulin-like growth factor I. Endocrinology 123: 2827-2833.
4. Mavalli MD, DiGirolamo DJ, Fan Y, Riddle RC, Campbell KS, et al. (2010) Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice. J Clin Invest 120: 4007-4020.
5. Fernandez AM, Dupont J, Farrar RP, Lee S, Stannard B, et al. (2002) Muscle-specific inactivation of the IGF-I receptor induces compensatory hyperplasia in skeletal muscle. J Clin Invest 109: 347-355.
6. Adams GR, McCue SA, (1998) Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats. J Appl Physiol 84: 1716-1722.
7. Musaro A, McCullagh K, Paul A, Houghton L, Dobrowolny G, et al. (2001) Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 27: 195-200.
8. Coleman ME, DeMayo F, Yin KC, Lee HM, Geske R, et al. (1995) Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J Biol Chem 270: 12109-12116.
9. Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N, Sweeney HL, (1998) Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci U S A 95: 15603-15607.
10. Barton ER, Morris L, Musaro A, Rosenthal N, Sweeney HL, (2002) Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J Cell Biol 157: 137-148.
11. Lynch GS, Cuffe SA, Plant DR, Gregorevic P, (2001) IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice. Neuromuscul Disord 11: 260-268.
12. Schertzer JD, Lynch GS, (2006) Comparative evaluation of IGF-I gene transfer and IGF-I protein administration for enhancing skeletal muscle regeneration after injury. Gene Ther 13: 1657-1664.
13. Rabinovsky ED, Gelir E, Gelir S, Lui H, Kattash M, et al. (2003) Targeted expression of IGF-1 transgene to skeletal muscle accelerates muscle and motor neuron regeneration. Faseb J 17: 53-55.
14. Quinn LS, Haugk KL, (1996) Overexpression of the type-1 insulin-like growth factor receptor increases ligand-dependent proliferation and differentiation in bovine skeletal myogenic cultures. J Cell Physiol 168: 34-41.
15. Florini JR, Ewton DZ, Coolican SA, (1996) Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 17: 481-517.
16. Adams GR, Haddad F, (1996) The relationships among IGF-1, DNA content, and protein accumulation during skeletal muscle hypertrophy. J Appl Physiol 81: 2509-2516.
17. Jennische E, Hansson HA, (1987) Regenerating skeletal muscle cells express insulin-like growth factor I. Acta Physiol Scand 130: 327-332.
18. Barton-Davis ER, Shoturma DI, Sweeney HL, (1999) Contribution of satellite cells to IGF-I induced hypertrophy of skeletal muscle. Acta Physiol Scand 167: 301-305.
19. Coolican SA, Samuel DS, Ewton DZ, McWade FJ, Florini JR, (1997) The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J Biol Chem 272: 6653-6662.
20. Johnson SE, Allen RE, (1990) The effects of bFGF, IGF-I, and TGF-beta on RMo skeletal muscle cell proliferation and differentiation. Exp Cell Res 187: 250-254.
21. Leloup L, Mazeres G, Daury L, Cottin P, Brustis JJ, (2006) Involvement of calpains in growth factor-mediated migration. Int J Biochem Cell Biol 38: 2049-2063.
22. Shimatsu A, Rotwein P, (1987) Mosaic evolution of the insulin-like growth factors. Organization, sequence, and expression of the rat insulin-like growth factor I gene. J Biol Chem 262: 7894-7900.
23. Rotwein P, (1986) Two insulin-like growth factor I messenger RNAs are expressed in human liver. Proc Natl Acad Sci U S A 83: 77-81.
24. Wallis M, (2009) New insulin-like growth factor (IGF)-precursor sequences from mammalian genomes: the molecular evolution of IGFs and associated peptides in primates. Growth Horm IGF Res 19: 12-23.
25. Lowe WL Jr, Lasky SR, LeRoith D, Roberts CT Jr, (1988) Distribution and regulation of rat insulin-like growth factor I messenger ribonucleic acids encoding alternative carboxyterminal E-peptides: evidence for differential processing and regulation in liver. Mol Endocrinol 2: 528-535.
26. Lund PK (1998) Insulin-like growth factors: gene structure and regulation. In: Conn PM, editor. Handbook of Physiology. Bethesda, MD: American Physiology Society. pp 537-571.
27. Shamblott MJ, Chen TT, (1993) Age-related and tissue-specific levels of five forms of insulin-like growth factor mRNA in a teleost. Mol Mar Biol Biotechnol 2: 351-361.
28. Duguay SJ, Lai-Zhang J, Steiner DF, (1995) Mutational analysis of the insulin-like growth factor I prohormone processing site. J Biol Chem 270: 17566-17574.
29. Duguay SJ, Milewski WM, Young BD, Nakayama K, Steiner DF, (1997) Processing of wild-type and mutant proinsulin-like growth factor-IA by subtilisin-related proprotein convertases. J Biol Chem 272: 6663-6670.
30. Duguay SJ, (1999) Post-translational processing of insulin-like growth factors. Horm Metab Res 31: 43-49.
31. Wilson HE, Westwood M, White A, Clayton PE, (2001) Monoclonal antibodies to the carboxy-terminal Ea sequence of pro-insulin-like growth factor-IA (proIGF-IA) recognize proIGF-IA secreted by IM9 B-lymphocytes. Growth Horm IGF Res 11: 10-17.
32. Conover CA, Baker BK, Bale LK, Clarkson JT, Liu F, et al. (1993) Human hepatoma cells synthesize and secrete insulin-like growth factor Ia prohormone under growth hormone control. Regul Pept 48: 1-8.
33. Conover CA, Baker BK, Hintz RL, (1989) Cultured human fibroblasts secrete insulin-like growth factor IA prohormone. J Clin Endocrinol Metab 69: 25-30.
34. Barton ER, (2006) The ABCs of IGF-I isoforms: impact on muscle hypertrophy and implications for repair. Appl Physiol Nutr Metab 31: 791-797.
35. Yang S, Alnaqeeb M, Simpson H, Goldspink G, (1996) Cloning and characterization of an IGF-1 isoform expressed in skeletal muscle subjected to stretch. J Muscle Res Cell Motil 17: 487-495.
36. McKoy G, Ashley W, Mander J, Yang SY, Williams N, et al. (1999) Expression of insulin growth factor-1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation. J Physiol 516 (Pt 2):: 583-592.
37. Yang H, Alnaqeeb M, Simpson H, Goldspink G, (1997) Changes in muscle fibre type, muscle mass and IGF-I gene expression in rabbit skeletal muscle subjected to stretch. J Anat 190 (Pt 4):: 613-622.
38. Goldspink G, (2005) Research on mechano growth factor: its potential for optimising physical training as well as misuse in doping. Br J Sports Med 39: 787-788 discussion 787-788.
39. Yang SY, Goldspink G, (2002) Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation. FEBS Lett 522: 156-160.
40. Mills P, Lafreniere JF, Benabdallah BF, El Fahime M, Tremblay JP, (2007) A new pro-migratory activity on human myogenic precursor cells for a synthetic peptide within the E domain of the mechano growth factor. Exp Cell Res 313: 527-537.
41. Mills P, Dominique JC, Lafreniere JF, Bouchentouf M, Tremblay JP, (2007) A synthetic mechano growth factor E Peptide enhances myogenic precursor cell transplantation success. Am J Transplant 7: 2247-2259.
42. Barton ER, (2006) Viral expression of insulin-like growth factor-I isoforms promotes different responses in skeletal muscle. J Appl Physiol 100: 1778-1784.
43. Pfeffer LA, Brisson BK, Lei H, Barton ER, (2009) The insulin-like growth factor (IGF)-I E-peptides modulate cell entry of the mature IGF-I protein. Mol Biol Cell 20: 3810-3817.
44. Mauro A, (1961) Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 9: 493-495.
45. Stavropoulou A, Halapas A, Sourla A, Philippou A, Papageorgiou E, et al. (2009) IGF-1 expression in infarcted myocardium and MGF E peptide actions in rat cardiomyocytes in vitro. Mol Med 15: 127-135.
46. Philippou A, Papageorgiou E, Bogdanis G, Halapas A, Sourla A, et al. (2009) Expression of IGF-1 isoforms after exercise-induced muscle damage in humans: characterization of the MGF E peptide actions in vitro. In Vivo 23: 567-575.
47. Garcia-Echeverria C, Pearson MA, Marti A, Meyer T, Mestan J, et al. (2004) In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase. Cancer Cell 5: 231-239.
48. Denley A, Bonython ER, Booker GW, Cosgrove LJ, Forbes BE, et al. (2004) Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR. Mol Endocrinol 18: 2502-2512.
49. Pietrzkowski Z, Lammers R, Carpenter G, Soderquist AM, Limardo M, et al. (1992) Constitutive expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor abrogates all requirements for exogenous growth factors. Cell Growth Differ 3: 199-205.
50. Vecchione A, Marchese A, Henry P, Rotin D, Morrione A, (2003) The Grb10/Nedd4 complex regulates ligand-induced ubiquitination and stability of the insulin-like growth factor I receptor. Mol Cell Biol 23: 3363-3372.
51. Musaro A, Rosenthal N, (1999) Maturation of the myogenic program is induced by postmitotic expression of insulin-like growth factor I. Mol Cell Biol 19: 3115-3124.
52. Matheny RW Jr, Nindl BC, (2011) Loss of IGF-IEa or IGF-IEb impairs myogenic differentiation. Endocrinology 152: 1923-1934.
53. Clemmons DR, Shaw DS, (1986) Purification and biologic properties of fibroblast somatomedin. J Biol Chem 261: 10293-10298.
54. Siegfried JM, Kasprzyk PG, Treston AM, Mulshine JL, Quinn KA, et al. (1992) A mitogenic peptide amide encoded within the E peptide domain of the insulin-like growth factor IB prohormone. Proc Natl Acad Sci U S A 89: 8107-8111.
55. Kuo YH, Chen TT, (2002) Novel activities of pro-IGF-I E peptides: regulation of morphological differentiation and anchorage-independent growth in human neuroblastoma cells. Exp Cell Res 280: 75-89.
56. Tian XC, Chen MJ, Pantschenko AG, Yang TJ, Chen TT, (1999) Recombinant E-peptides of pro-IGF-I have mitogenic activity. Endocrinology 140: 3387-3390.
57. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR, (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A 92: 7686-7689.
58. Leloup L, Daury L, Mazeres G, Cottin P, Brustis JJ, (2007) Involvement of the ERK/MAP kinase signalling pathway in milli-calpain activation and myogenic cell migration. Int J Biochem Cell Biol 39: 1177-1189.
59. Matheny RW Jr, Nindl BC, Adamo ML, (2010) Minireview: Mechano-growth factor: a putative product of IGF-I gene expression involved in tissue repair and regeneration. Endocrinology 151: 865-875.
60. Kandalla PK, Goldspink G, Butler-Browne G, Mouly V, (2011) Mechano Growth Factor E peptide (MGF-E), derived from an isoform of IGF-1, activates human muscle progenitor cells and induces an increase in their fusion potential at different ages. Mech Ageing Dev 132 (4):: 154-162.
61. Chow JC, Condorelli G, Smith RJ, (1998) Insulin-like growth factor-I receptor internalization regulates signaling via the Shc/mitogen-activated protein kinase pathway, but not the insulin receptor substrate-1 pathway. J Biol Chem 273: 4672-4680.
62. Girnita L, Shenoy SK, Sehat B, Vasilcanu R, Vasilcanu D, et al. (2007) Beta-arrestin and Mdm2 mediate IGF-1 receptor-stimulated ERK activation and cell cycle progression. J Biol Chem 282: 11329-11338.
63. Vasilcanu R, Vasilcanu D, Sehat B, Yin S, Girnita A, et al. (2008) Insulin-like growth factor type-I receptor-dependent phosphorylation of extracellular signal-regulated kinase 1/2 but not Akt (protein kinase B) can be induced by picropodophyllin. Mol Pharmacol 73: 930-939.
64. Sehat B, Andersson S, Vasilcanu R, Girnita L, Larsson O, (2007) Role of ubiquitination in IGF-1 receptor signaling and degradation. PLoS One 2: e340.
65. Ates K, Yang SY, Orrell RW, Sinanan AC, Simons P, et al. (2007) The IGF-I splice variant MGF increases progenitor cells in ALS, dystrophic, and normal muscle. FEBS Lett 581: 2727-2732.
66. Hailey J, Maxwell E, Koukouras K, Bishop WR, Pachter JA, et al. (2002) Neutralizing anti-insulin-like growth factor receptor 1 antibodies inhibit receptor function and induce receptor degradation in tumor cells. Mol Cancer Ther 1: 1349-1353.
67. Bulayeva NN, Gametchu B, Watson CS, (2004) Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways. Steroids 69: 181-192.
68. Schwarz AJ, Brasel JA, Hintz RL, Mohan S, Cooper DM, (1996) Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men. J Clin Endocrinol Metab 81: 3492-3497.
69. Philippou A, Stavropoulou A, Sourla A, Pissimissis N, Halapas A, et al. (2008) Characterization of a rabbit antihuman mechano growth factor (MGF) polyclonal antibody against the last 24 amino acids of the E domain. In Vivo 22: 27-35.
70. Chen X, Li Y, (2009) Role of matrix metalloproteinases in skeletal muscle: migration, differentiation, regeneration and fibrosis. Cell Adh Migr 3: 337-341.
71. Barton ER, DeMeo J, Lei H, (2010) The insulin-like growth factor (IGF)-I E-peptides are required for isoform-specific gene expression and muscle hypertrophy after local IGF-I production. J Appl Physiol 108: 1069-1076.
72. Wu N, Opalenik S, Liu J, Jansen ED, Giro MG, et al. (2002) Real-time visualization of MMP-13 promoter activity in transgenic mice. Matrix Biol 21: 149-161.
73. Wu N, Jansen ED, Davidson JM, (2003) Comparison of mouse matrix metalloproteinase 13 expression in free-electron laser and scalpel incisions during wound healing. J Invest Dermatol 121: 926-932.
74. Heidegger I, Pircher A, Klocker H, Massoner P, (2011) Targeting the insulin-like growth factor network in cancer therapy. Cancer Biol Ther 11: 701-707.
75. Denley A, Wang CC, McNeil KA, Walenkamp MJ, van Duyvenvoorde H, et al. (2005) Structural and functional characteristics of the Val44Met insulin-like growth factor I missense mutation: correlation with effects on growth and development. Mol Endocrinol 19: 711-721.
76. Romanelli RJ, LeBeau AP, Fulmer CG, Lazzarino DA, Hochberg A, et al. (2007) Insulin-like growth factor type-I receptor internalization and recycling mediate the sustained phosphorylation of Akt. J Biol Chem 282: 22513-22524.